Berberine is a bitter, bright-yellow plant alkaloid, the active compound in the Chinese herb Huang Lian. Chinese medicine has used Huang Lian for centuries to clear Damp-Heat in stubborn digestive and infectious complaints. In type 2 diabetes it lowers HbA1c about 0.6 to 0.9 points and fasting glucose about 15 mg/dL (0.8 mmol/L). That is close to metformin in the few small head-to-head trials.
LDL cholesterol falls about 18 to 25 mg/dL (0.5 mmol/L), and triglycerides drop with it. Those effects are smaller and far less studied than the viral 'nature's Ozempic' label implies. Berberine also interacts with many drugs and adds to the effect of diabetes medication. Anyone on medication should clear it with a prescriber before starting.
Findings & Outcomes
What It Is
Berberine is a plant alkaloid, the compound that gives the Chinese herb Huang Lian its yellow color. Under 1% of a swallowed dose reaches the bloodstream, because the gut wall and liver break it down first. Most of it never leaves the gut.
What It Does
Berberine's best-studied effect in type 2 diabetes is on blood sugar; it lowers both fasting glucose and HbA1c. LDL cholesterol and triglycerides come down too, from the same metabolic action. The evidence for the lipid effect is weaker than for blood sugar.
Type 2 diabetes is, in large part, a manufactured disease. In large cohort studies, diets highest in ultra-processed food carry roughly a 15% higher risk of it per 10% of daily intake.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Evidence And Methods
The diabetes evidence is mostly small, short, single-country trials
The evidence that berberine lowers blood sugar leans on many small studies from one part of the world, of mixed quality. That does not make it wrong, but it means the size of the effect could shrink when larger, better-run trials are done.
The meta-analyzes that produce berberine's glucose numbers (Lan 2015, Xie 2022) draw almost entirely on trials run in China, many small and short, with limited blinding and allocation detail and high between-study heterogeneity. Reviewers repeatedly flag these limits. Small positive trials also reach print more readily than small null ones, which can lift a pooled average above the truth.
Who this may not transfer to:This is a claim about the quality of the evidence base, not a measured outcome in people.
The studies · 2
Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension · J Ethnopharmacol 2015
Xie et al., Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis · Front Pharmacol 2022
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Cholesterol And Lipids
Lowers LDL cholesterol about 18–25 mg/dL (0.5 mmol/L)
Berberine brought LDL, the cholesterol linked to heart disease, down by a modest but real amount in the trials, in the same ballpark as its effect on total cholesterol.
Dong and colleagues (2013) pooled 11 randomized trials in 874 participants and found berberine reduced total cholesterol (about 24 mg/dL (0.61 mmol/L)), LDL cholesterol (about 25 mg/dL (0.65 mmol/L)) and triglycerides versus control. Blais and colleagues (2023) confirmed the reductions in a larger meta-analysis of placebo-controlled trials (LDL about 18 mg/dL (0.46 mmol/L); total cholesterol about 19 mg/dL (0.48 mmol/L)) and, examining sex, found the difference between men and women was mainly in HDL cholesterol, not in LDL. The size is meaningful but smaller and far less studied than a standard statin.
Who this may not transfer to:Blais 2023 found the main sex difference was in HDL cholesterol; the LDL reduction was similar in men and women.
For someone with borderline lipids who wants a diet-and-lifestyle-adjacent option, this is a meaningful effect worth discussing with a clinician. It is not a reason to stop or refuse a statin where one is indicated, and berberine can raise statin levels if the two are combined (see the cautions).
The studies · 2
Dong et al., The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials · Planta Med 2013
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
Lowers triglycerides about 30–44 mg/dL (0.34–0.50 mmol/L)
Berberine also nudged triglycerides down, the blood fat that tracks with metabolic problems, by a small but consistent amount in the trials.
The same meta-analyzes that measured cholesterol (Dong 2013, Blais 2023) reported a reduction in triglycerides with berberine versus control, about 30–44 mg/dL (0.34–0.50 mmol/L). The triglyceride change tends to move in step with the glucose and cholesterol effects, which fits berberine acting on a shared metabolic pathway, not on lipids alone.
Who this may not transfer to:Drawn from mixed-sex trials; the triglyceride effect has not been separately established for women alone.
The lipid and glucose effects cluster together, so berberine is best thought of as a mild metabolic agent, not a targeted triglyceride treatment. Anyone with very high triglycerides needs a clinician-directed plan, not a supplement on its own.
The studies · 2
Dong et al., The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials · Planta Med 2013
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
How it works
Under about 1% of an oral dose is absorbed
Almost none of a berberine dose gets into the blood, under about 1%, because the gut and liver break it down first. That is why it is taken several times a day, and why a lot of its effect may come from what it does inside the gut.
Liu and colleagues (2010) traced berberine's very low plasma levels in rats to extensive intestinal first-pass elimination and heavy distribution into the liver, so little intact berberine circulates. This poor bioavailability shapes how it is dosed (split through the day) and points to gut-level effects, including on the microbiome, as part of how it works.
The study · 1
Liu et al., Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats · Drug Metab Dispos 2010
Raises liver LDL receptors to clear more cholesterol, a route unlike statins
Berberine appears to make liver cells display more of the receptors that pull LDL out of the blood, a different mechanism from statins. This is lab and animal evidence explaining the human cholesterol effect.
Kong and colleagues (2004) showed in cultured human liver cells, in hyperlipidemic hamsters, and in a group of hypercholesterolemic patients that berberine upregulates the LDL receptor by stabilizing its messenger RNA through an ERK-dependent pathway, not by blocking cholesterol synthesis the way statins do. Because the mechanisms differ, the authors proposed the two could be complementary. This is mechanistic evidence, not a clinical outcome.
The study · 1
Kong et al., Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins · Nat Med 2004;10(12):1344-1351
Works through AMPK like metformin, not the GLP-1 pathway of Ozempic
The way berberine works on metabolism resembles metformin, through an energy-sensing switch called AMPK, not the gut-hormone pathway that the weight-loss injections use. Mechanistically it works like metformin, not like Ozempic.
Turner and colleagues (2008) showed berberine and its derivative dihydroberberine inhibit mitochondrial respiratory complex I, raising cellular AMP and activating AMP-activated protein kinase (AMPK), which improves insulin action; this is the same target metformin engages. GLP-1 drugs such as semaglutide act on an entirely different system, the incretin receptors that govern appetite and insulin release. The popular 'nature's Ozempic' framing conflates two unrelated mechanisms.
The study · 1
Turner et al., Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMPK and improve insulin action · Diabetes 2008;57(5):1414-1418
Blood Sugar
Lowers HbA1c about 0.6 to 0.9 points in type 2 diabetes
Berberine brought blood sugar down in people with type 2 diabetes, by an amount that looked similar to metformin in the trials done so far. The trials are small and mostly from China, so the true size is less settled than that figure suggests.
Lan and colleagues (2015) pooled 27 randomized trials in 2,569 patients and found berberine lowered fasting and post-meal glucose and HbA1c, with reductions comparable to oral glucose-lowering drugs in head-to-head arms and an added benefit when berberine was combined with those drugs. Xie and colleagues (2022) reached the same direction in a later systematic review and meta-analysis of the glucose-lowering effect. Both reviews note the trials are of limited quality, so the pooled averages carry a wide margin.
Who this may not transfer to:Most berberine diabetes trials do not report a clean sex split, so how evenly the effect applies to women is not established.
This is a meaningful effect, but it comes from short trials in one region. For someone already managing diabetes with medication, berberine is something to add under a clinician's eye and with glucose monitoring, not a swap for a prescribed drug.
The studies · 2
Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension · J Ethnopharmacol 2015
Xie et al., Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis · Front Pharmacol 2022
Counts once: this finding and 1 other here come from the same source, so they are one body of evidence, not separate confirmations.
In one 36-person trial, HbA1c fell from 9.5% to 7.5%, close to metformin
In one small trial, berberine dropped long-term blood sugar about as much as metformin over three months. It is the trial most often cited for the metformin comparison, and it is a single, modest study.
Yin, Xing and Ye (2008) ran two studies. In the first, 36 adults with newly diagnosed type 2 diabetes were randomized to berberine or metformin for 3 months; HbA1c fell from 9.5% to 7.5% on berberine, comparable to the metformin arm, alongside drops in fasting and post-meal glucose and in triglycerides. In the second, berberine added to existing treatment in poorly controlled patients improved glucose further.
Who this may not transfer to:A single small trial in one center; the sex breakdown of the randomized arm is not clearly reported.
One 36-person open comparison is where the 'as good as metformin' claim comes from. It supports berberine being active, not berberine replacing a first-line drug with decades of outcome data behind it.
The study · 1
Yin, Xing, Ye, Efficacy of berberine in patients with type 2 diabetes mellitus · Metabolism 2008;57(5):712-717
How It Works
Berberine's blood-sugar and lipid effects come from human trials. How it produces them is worked out mostly in cell and animal studies. The core switch is AMPK, an energy sensor inside the cell, and metformin acts on the same switch. Semaglutide, the drug in Ozempic, acts on a different system, GLP-1. Berberine lowers LDL cholesterol through a separate route in the liver.
Anatomy of the Practice
1In the gut
Little berberine is absorbed, so most of it stays in the gut and acts there, including on the gut bacteria. That poor absorption is the reason the dose is divided and taken with food.
2In the liver and muscle
The fraction that reaches the bloodstream mildly blocks one step in the cell energy chain. That activates AMPK and shifts the cell toward burning glucose and fat for energy.
3On the LDL receptor
In liver cells, berberine increases the number of LDL receptors, the receptors that pull cholesterol out of the blood. This is shown mainly in cell and animal work so far.
Is Berberine "Nature's Ozempic"?
The "nature's Ozempic" label oversells a modest effect and names the wrong drug. Semaglutide produces large, reliable weight loss through GLP-1. Berberine's effect on weight is small and inconsistent, so the comparison misleads. That drop comes from trials that are mostly small, short, run in one region, and uneven in quality. Reviews agree berberine lowers blood sugar; how much is still uncertain and could change with larger trials.
The drug it resembles is metformin, and the shared benefit is a modest blood-sugar drop.
Berberine is not the first move for type 2 diabetes. Losing weight and moving daily do more than any supplement, and berberine works best added to that.
How to Take It
Ways to Do It
The routine is a split daily dose with meals, tracked by lab numbers over a few weeks. If you take any medication, read the interactions in the Cautions below first.
Most trials used roughly 1,000 to 1,500 mg a day, split into 500 mg taken two or three times daily with food. There is no loading phase and no benefit to a single large dose.
Food blunts the digestive side effects, which are worst at larger single doses. If it upsets your stomach, drop to the lower end and build up slowly.
The metabolic effects take weeks to show up. Track the numbers directly. Check fasting glucose and HbA1c for blood sugar, and a lipid panel for cholesterol and triglycerides. You can order these yourself or have them run the usual way. Check them before a trial period and again after, instead of judging by feel. If you take diabetes medication, track these numbers with your prescriber as berberine takes effect.
Go Deeper
Berberine is measured mostly in type 2 diabetes, and it sits beside the biology, conditions, and diet levers that move the same numbers:
- insulin and glucose
- Type 2 diabetes
- Weight and metabolic health
- Cholesterol and lipids
- Metformin
- Ketogenic diet
The Chinese Medicine View
Huang Lian (Coptis chinensis, Chinese goldthread) supplies berberine as its principal active constituent. Berberine also appears in Huang Bai (Phellodendron) and other yellow, bitter herbs. Chinese medicine classifies Huang Lian as bitter and cold, and uses it to clear Heat and drain Damp-Heat, chiefly from the Heart and Stomach. Practitioners give it for red, hot, damp patterns: certain kinds of dysentery, mouth and tongue sores, irritability, and heat in the middle burner.
The classical actions belong to the whole herb as it is used in practice. The tradition matches Huang Lian to a pattern and combines it with other herbs in a formula. The modern trials test one purified compound at a fixed dose in type 2 diabetes, regardless of pattern. Classical texts caution against long use of Huang Lian in weak, cold, or deficient patients; the same coldness that clears Damp-Heat can injure Spleen and Stomach yang.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Constipation, diarrhea and cramping, usually mild and dose-related
The berberine trials report no serious adverse reactions (Lan 2015); gastrointestinal complaints are the commonly described effects, generally transient and mild and more likely at larger single doses. Splitting the dose and taking it with meals is the standard way to reduce them.Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
Inhibits CYP3A4 and P-glycoprotein, raising levels of many drugs
Qiu and colleagues (2009) showed in animal pharmacokinetics that berberine raised levels of P-glycoprotein substrates such as digoxin and cyclosporine, without a significant change in CYP3A activity in that study. A 2025 review of berberine's effects on cytochrome P450 (Bathaei 2025) summarizes its inhibition of CYP3A4 and other isoenzymes. Because CYP3A4 and P-glycoprotein between them clear a large fraction of common medications, inhibiting them can raise co-administered drug concentrations.Qiu et al., Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gpBathaei et al., Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review
Raises cyclosporine levels about 29% in transplant patients
Wu and colleagues (2005) studied renal transplant recipients on cyclosporine A and found that co-administering berberine increased cyclosporine trough concentrations by about 29% and altered its pharmacokinetics, consistent with berberine inhibiting CYP3A4. Cyclosporine has a narrow therapeutic index, so a change of this size can move a patient from a safe level toward toxicity or, if unmanaged, rejection.Wu et al., Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
Avoid in pregnancy, breastfeeding and newborns: bilirubin and kernicterus risk
Chan (1993) found berberine displaces bilirubin from albumin far more strongly than phenylbutazone, a known potent displacer, and in rats raised unbound and total serum bilirubin; the paper concludes berberine-containing herbs are best avoided in jaundiced neonates and in pregnancy. In a newborn, rising free bilirubin can cross into the brain and cause kernicterus. Linn and colleagues (2012) later re-examined the hemolysis concern and found traditional-dose Coptis and Phellodendron did not aggravate anemia in adults with chronic blood disorders, while the neonatal and G6PD-deficiency cautions remain the reason to avoid it there.Chan, Displacement of bilirubin from albumin by berberineLinn et al., Berberine-induced haemolysis revisited: safety of Rhizoma coptidis and Cortex phellodendri in chronic haematological diseases
Can push blood sugar too low when added to diabetes medication
The same meta-analyzes that establish berberine's glucose-lowering effect (Lan 2015) also show it adds to the effect of oral diabetes drugs when combined, which is the flip side of the benefit: combined with agents that already lower glucose, or with insulin, the additive drop can reach hypoglycemia. The Yin 2008 trials likewise document meaningful glucose lowering that would compound existing treatment.Lan et al., Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertensionYin, Xing, Ye, Efficacy of berberine in patients with type 2 diabetes mellitus
Do not use in pregnancy, breastfeeding, or in newborns
This is the only absolute contraindication. Berberine can displace bilirubin from the blood proteins that carry it, and it can break down red blood cells. In a newborn, rising free bilirubin can cross into the brain and cause kernicterus, a serious brain injury. For that reason berberine and berberine-containing herbs are avoided in pregnancy, during breastfeeding, and in infants. People with G6PD deficiency should be cautious for the same hemolysis reason.
It interacts with many prescription drugs
Berberine inhibits CYP3A4 and P-glycoprotein, the enzyme and transporter that clear a large share of medications. Through them it can raise the blood levels of statins, some blood-pressure and heart-rhythm drugs, sedatives, certain blood thinners, and immunosuppressants. In transplant patients, adding berberine raised levels of the anti-rejection drug cyclosporine by about 29%, a meaningful shift for a narrow-margin drug. If you take any prescription medicine, clear berberine with your prescriber or pharmacist before starting.
It can push blood sugar too low with diabetes medication
Because berberine lowers glucose on its own, taking it with insulin, sulfonylureas, or other glucose-lowering drugs adds to their effect and can drop blood sugar too far, into hypoglycemia. If you take diabetes medication, start and dose berberine with whoever manages that medication, with blood-sugar monitoring, so the dose can be adjusted instead of the two simply stacking.
Digestive side effects are common
Constipation, diarrhea, abdominal cramping, gas, and a bitter taste are the usual complaints. They are generally mild and dose-related, and they cluster at larger single doses. They usually settle when you split the dose, take it with meals, and start at the lower end.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
What is HbA1c?
HbA1c is the standard measure of blood-sugar control in type 2 diabetes: the average blood sugar over about three months, written as a single percentage. A one-off fasting glucose reading catches a single moment; HbA1c catches the trend.
Which plants contain berberine?
Berberine is the same yellow alkaloid in four plants used as medicine: Chinese goldthread (Coptis, the source of Huang Lian), barberry, Oregon grape, and goldenseal. Their shared yellow color comes from it.
Which drugs are riskiest to combine with berberine?
The riskiest are narrow-margin drugs, where a small rise in blood level can cause harm. Warfarin, a blood thinner, and tacrolimus, a transplant drug, are the clearest examples.
Is berberine as effective as metformin?
In pooled randomized trials and a few head-to-head studies, berberine lowered blood sugar by about as much as metformin. Those direct comparisons are too few to treat the match as settled.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 20 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.